Canada· CA-DIN-02526263
PALYNZIQ
A pegvaliase product containing pegvaliase, registered in Canada by BIOMARIN INTERNATIONAL LIMITED. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Pegvaliase is registered in 10 of 19 countries.
Countries holding a registration under ATC A16AB19 (pegvaliase), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Pegvaliase · ATC A16AB19
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- PEGVALIASE
- Manufacturer
- BIOMARIN INTERNATIONAL LIMITED
- Country
- Canada (CA)
- ATC code
- A16AB19
- ATC class
- Pegvaliase
- Defined daily dose
- 30 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for pegvaliase.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pegvaliase · interactions on record
20 records
- 20 moderate
Most severe, free to view
- NaloxegolA06AH03moderate
- Coagulation factor IX, II, VII and X in combinationB02BD01moderate
- Coagulation factor VIIIB02BD02moderate
- Coagulation factor IXB02BD04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pegvaliase in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPALYNZIQBioMarin International Limited, Dublin
- United StatesPalynziqBioMarin Pharmaceutical Inc.
- BelgiumPalynziq 10 mgBioMarin International
- SpainPALYNZIQ 10 MG SOLUCION INYECTABLE EN JERINGA PRECARGADABiomarin International Limited
- FinlandPalynziqBiomarin International Limited
- IrelandPalynziq 10 mg Solution for injectionBiomarin International Limited
- IcelandPALYNZIQBioMarin International Limited
- Japanペグバリアーゼ（遺伝子組換え）ＢｉｏＭａｒｉｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｊａｐａｎ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Palynziq
- Liechtenstein · Palynziq
- Norway · Palynziq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7fb9d6a9-e3d1-4df3-b2e7-347f146061fa GET /v1/drugs/7fb9d6a9-e3d1-4df3-b2e7-347f146061fa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02526263",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A16AB19",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "101538",
"strengths": [
"20 MG"
],
"ahfs_class": null,
"substances": [
"PEGVALIASE"
],
"product_categorization": null
}See everything about pegvaliase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.